Back to
Royal Bank of Canada
NVAX
Showing 8 of 28 quarters
Position history for
Royal Bank of Canada's holdings in Novavax, Inc.
Yes. Royal Bank of Canada holds 25,759 shares of NVAX (Novavax), worth $242,000, as of its Q2 2026 13F filing. It increased the position by 12,272 shares (+91.0%) from Q1 2026. Royal Bank of Canada has held NVAX in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$242,000
Current Shares
25,759
Total Value Change
-$127,000
Total Shares Change
-3,543
Quarter-by-Quarter History